Our Services
Medical Information
Helpful Resources
Published on: 10/9/2026
Short-term options such as melatonin, antihistamines like diphenhydramine or doxylamine, and prescription medications including zolpidem, eszopiclone, zaleplon, and ramelteon are generally considered safe for most healthy adults, but the recommended duration varies widely, from a few nights to several weeks. Melatonin is typically used for days to a few weeks, over-the-counter antihistamines are not advised beyond about two weeks because of tolerance and next-day grogginess, and prescription hypnotics are usually prescribed for two to four weeks with ongoing medical supervision. Cognitive behavioral therapy for insomnia remains the only approach proven safe for long-term use, which matters if your sleep problems last more than three months. Age, pregnancy, kidney or liver function, alcohol use, and interactions with other medications all change what is safe for you, so there are several important factors to consider before starting or continuing any sleep aid. See below for the complete answer, including specific dosing windows, withdrawal and rebound insomnia risks, and warning signs that your insomnia needs evaluation rather than another pill.
Persistent trouble sleeping is often a symptom rather than a diagnosis, and conditions like sleep apnea, restless legs syndrome, thyroid disorders, depression, anxiety, and chronic pain are commonly masked by sleep aids instead of treated. If you are reaching for something to help you sleep more nights than not, it is worth spending a few minutes on a free, instant, online symptom check to see which underlying causes fit your pattern. It will help you decide whether to adjust your approach, speak with a pharmacist, or book an appointment, and it gives you clearer language to describe what is happening when you do.
Last reviewed for medical accuracy: 10/08/2026
Having trouble falling or staying asleep happens to many people at some point. Short-term use of sleep aids can help reset your sleep pattern, but safety and duration of use vary by type. Below is an overview—based on guidance from the U.S. Food and Drug Administration (FDA), the American Academy of Sleep Medicine (AASM) and other credible sources—of common “safe sleep pills” and how long they’re generally considered appropriate.
Diphenhydramine (e.g., Benadryl®) and Doxylamine (e.g., Unisom®)
• Mechanism: First-generation antihistamines with sedating side effects
• Typical dose: Diphenhydramine 25–50 mg; Doxylamine 12.5–25 mg, 30 minutes before bed
• Duration: Generally safe for occasional, short-term use (up to 7–14 consecutive nights)
• Notes:
Melatonin
• Mechanism: A hormone that helps regulate the sleep-wake cycle
• Typical dose: 0.3–5 mg taken 30–60 minutes before bedtime
• Duration:
Valerian Root
• Mechanism: An herbal supplement thought to affect GABA receptors
• Typical dose: 300–600 mg of extract, 30–120 minutes before bed
• Duration: Studied safely for up to 4–6 weeks in clinical trials
• Notes:
Zolpidem (Ambien®), Zaleplon (Sonata®), Eszopiclone (Lunesta®)
• Mechanism: Bind to benzodiazepine receptors, promoting sedation
• Typical duration of use: Short-term—usually 2–4 weeks
• Notes:
Temazepam (Restoril®), Triazolam (Halcion®), Others
• Mechanism: Enhance the effect of GABA, a calming neurotransmitter
• Typical duration of use: Very short-term—2–4 weeks max
• Notes:
Ramelteon (Rozerem®)
• Mechanism: Selective melatonin receptor (MT1/MT2) agonist
• Duration: Can be used longer-term; studies up to 1 year show a favorable safety profile
• Notes:
Suvorexant (Belsomra®)
• Mechanism: Blocks orexin, a wake-promoting neurotransmitter
• Duration: Approved for chronic insomnia; studied safely for up to 12 months
• Notes:
Doxepin (Silenor®)
• Mechanism: At low doses, blocks histamine H1 receptors to promote sleep maintenance
• Duration: Approved for up to 12 weeks; off-label use sometimes extends longer under supervision
• Notes:
While not FDA-approved for insomnia, some people try:
• Chamomile tea or extract
• Passionflower
• Lavender (aromatherapy)
Evidence is limited and product quality varies. Discuss with a healthcare provider before combining with other sleep aids.
Medication works best alongside behavioral changes:
• Establish a consistent sleep schedule.
• Create a comfortable, dark, quiet bedroom.
• Limit caffeine, nicotine and screens before bed.
• Try relaxation techniques (deep breathing, progressive muscle relaxation).
• Consider cognitive behavioral therapy for insomnia (CBT-I), which can provide lasting benefit.
If insomnia persists beyond 2–4 weeks, significantly impacts daily life, or is accompanied by alarming symptoms (chest pain, significant weight change, mood disturbances), speak to a doctor. For a quick, free, online symptom check, using the doctor approved Ubie Symptom Checker you can click here.
Always consult your healthcare provider before starting or stopping any sleep aid—especially if you have underlying conditions or take other medications. If you experience severe side effects, such as breathing problems, confusion or worsening mental health, seek medical attention right away.
This information is meant to guide and should not replace personalized medical advice. Please speak to a doctor if you have any life-threatening or serious concerns.
(References)
* Hofsø K, Coyer FM. Part 2. Chemical and physical restraints in the management of mechanically ventilated patients in the ICU: a patient perspective. Intensive Crit Care Nurs. 2007 Dec;23(6):316-22. doi: 10.1016/j.iccn.2007.04.002. Epub 2007 May 23. PMID: 17512200.
* Roehrs T, Roth T. Insomnia pharmacotherapy. Neurotherapeutics. 2012 Oct;9(4):728-38. doi: 10.1007/s13311-012-0148-3. PMID: 22976558; PMCID: PMC3480571.
* Herxheimer A. Jet lag. BMJ Clin Evid. 2014 Apr 29;2014. Epub 2014 Apr 29. PMID: 24780537; PMCID: PMC4006102.
* Manojlovich M, Ratz D, Miller MA, Krein SL. Use of Daily Interruption of Sedation and Early Mobility in US Hospitals. J Nurs Care Qual. 2017 Jan/Mar;32(1):71-76. doi: 10.1097/NCQ.0000000000000222. PMID: 27482874.
* Schroeck JL, Ford J, Conway EL, Kurtzhalts KE, Gee ME, Vollmer KA, Mergenhagen KA. Review of Safety and Efficacy of Sleep Medicines in Older Adults. Clin Ther. 2016 Nov;38(11):2340-2372. doi: 10.1016/j.clinthera.2016.09.010. Epub 2016 Oct 15. PMID: 27751669.
* Lee S. Dexmedetomidine: present and future directions. Korean J Anesthesiol. 2019 Aug;72(4):323-330. doi: 10.4097/kja.19259. Epub 2019 Jun 21. PMID: 31220910; PMCID: PMC6676029.
* Kleiman AM, Johnson KB. Untapped Potential of Dexmedetomidine. Anesth Analg. 2019 Dec;129(6):1450-1453. doi: 10.1213/ANE.0000000000004411. PMID: 31743160.
* Madari S, Golebiowski R, Mansukhani MP, Kolla BP. Pharmacological Management of Insomnia. Neurotherapeutics. 2021 Jan;18(1):44-52. doi: 10.1007/s13311-021-01010-z. Epub 2021 Feb 1. PMID: 33527255; PMCID: PMC8116439.
* Lou BX, Oks M. Insomnia: Pharmacologic Treatment. Clin Geriatr Med. 2021 Aug;37(3):401-415. doi: 10.1016/j.cger.2021.04.003. Epub 2021 Jun 4. PMID: 34210446.
* Peng L, Morford KL, Levander XA. Benzodiazepines and Related Sedatives. Med Clin North Am. 2022 Jan;106(1):113-129. doi: 10.1016/j.mcna.2021.08.012. PMID: 34823725.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.